AVX-89754-51417
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 497 / MI
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Moderna
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-14
- 2021-01-17
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Injection site discomfort, Injection site erythema, Injection site swelling, Injection site warmth — Feeling: GoodFree text: 14 days after vaccine developed red, raised, hard and warm to touch area where injection site was. 48 hrs it resolved. No issues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-02-05
Dose 2 — Moderna
- 2021-02-05
- 2021-02-06
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-08-08
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Chills, Cough, Fatigue, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Tested positive x2 for COVID. Dec 1st on a rapid - s/sx: headache, fatigue, cough. Jan 26th positive on Rapid and received PCR results confirming positive results. s/sx: headache, cough, sore throat, fever and chills. · Healthcare visit (other): Received monoclonal antibody infusion on Dec 3rd. 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-05 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — day 14, dose 1
Symptoms: 14 days after vaccine developed red, raised, hard and warm to touch area where injection site was. 48 hrs it resolved. No issues.
Release 11 — 12 months, dose 2
Symptoms: Tested positive x2 for COVID. Dec 1st on a rapid - s/sx: headache, fatigue, cough. Jan 26th positive on Rapid and received PCR results confirming positive results. s/sx: headache, cough, sore throat, fever and chills.
Healthcare visit (other): Received monoclonal antibody infusion on Dec 3rd. 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site discomfort | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release